FDA Investigator Jennifer C Johnson

Jennifer C Johnson has conducted inspections on 120 sites in 5 countries as of 23 Aug 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
120
Last Inspection Date:
23 Aug 2016
Investigator Role:
FDA Investigator
Redica ID:
100004205
Countries of Inspections:
United States of America, Mexico, Guatemala, India, Germany
FDA Investigators that have inspected at least one site in common with Jennifer C Johnson:
Adam J Taylor, Alan Escalona, Alan M Roberts, Alicia M Mozzachio, Alois P Provost, Amanda B Vega, Amanda S Zorn, Amy Devlin, PhD, Amy Wyan Mai, Ana E Morales, Ana L Kewes, Anders W Evenson, Andrew A Leboeuf, Anthony R Ronga, Antoinette L Chancey, Ashley L Reiber, Barbara A Rusin, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Brittany R Laymon, Bruce H Mccullough, Carl A Huffman, III, Carol F Robinson, Carrie Ann Plucinski, Celeta S Coves, Chad E Schmear, Chad J Whitwell, Charlie P Booker, Chase S Baldwin, Christina A Miller, Christopher D Leach, Clotia Cabbey Mensah, Colleen E Burke, Corey K Reno, Daniel B Arrecis, Dariusz Galezowski, Darla J Christopher, Darrell E Luedtke, Debra I Love, Debra Lboyd Seale, Decarlos A Gomez, Denarvis C Mendenhall, Donna A Katz, Donna K Speer, Doretha M Tonkins, Dr. Mark J Seaton, PhD, Edwardstine J Reese, Elizabeth L Holmes, Elizabeth Watkins, Emily S Mcgann, Eric S Pittman, Erin M Mcdowell, Erma Zaimova, Esther A Ofori, Frank Wackes, Gabryelle J Solverud, Gene R Gunn, Hans T Meyers, Hoimay Chan, Humera T Khan, James L Finn, James P Duggan, James W Plucinski, Jason F Chancey, Jayne E Holcomb, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer A Lavery, Jennifer C Adams, Jesse A Vazquez, Jessica L Burley, Jocelyn C Turner, John A Iwen, Jonathan G Swoboda, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Karen Emasley Joseph, Kathleen S Tormey, Kenneth L Smalls, Kevin T Gerrity, Kristen E Szenderski, Kujtim Sadiku, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Laurie A Haxel, Lawrence J Stringer, LCDR Mark A Jimenez, RN, Lee Terry Moore, Lequita M Mayhew, Lesley Maep Lutao, Leslie D Hintz, Liliya V Bubiy, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Marcia A Worley, Margaret Torres Vazquez, Maria Diaz, Marisa E Stock, Mark G Peterson, Mark I Kaspar, Martin R Vowell, Matthew J Gretkierewicz, Matthew J Sienko, Matthew R Buenconsejo, Michael D Robinson, Michael R Giammanco, Michele L Glendenning, Milva E Melendez Perales, Myla D Chapman, Nantie, Neali H Lucas, Nicholas F Lyons, Nicholas P Diorio, Nicholas Z Lu, Nicole C Victoria, PhD, Nicole J Clausen, Norman L Brown, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Paul L Bellamy, Paul M Chefor, Paula A Trost, Paula P Demichael, Peng Zhou, Phung Thien Nguyen, Rafael Padilla, Ralph A Erickson, Randy D Baxter, Raquel L Coleman, Renee L Anderson, Robert J Nesselhauf, Roberta W Cunningham, Roger J Adams, Rosemary Wood Sexton, Roshni J Patel, Russell K Riley, Ryan Gibson, Ryan S Martin, Samuel W Labinjo, Sarah Forney, Sarah L Roman, Sarah Nwandiuko, Shafiq S Ahadi, Shalonda C Clifford, Shana L Williams, Sherea L Dillon, Simone E Pitts, Sinuet P Yashikiramoto, Stefen D Mcmillan, Stephanie Mangigian, MS/OSH, RN, Stephen D Eich, Stuart W Russell, Sullan, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan P Bruederle, Susan W Ciani, Tamara M Qtami, Tamara Qtami, Tara A Marshall, Tara C Alcazar, Tara K Carmody, Tara M Carolfi, Tara R Gooen, That Q Dang, Thomas L Bellonte, Thunder N Dunkijacobs, Timothy Brennan, Todd M Stankewicz, Tong Jen Fu, PhD, Tong Zhou, Travis S Bradley, Uruaku A Obasi, Wayne D Stowell, Wayne E Seifert, Wayne W Grundstrom, Wendy G Tan, PhD, William D Sherman, William G Nelson, William R Weissinger, Yuanyuan Li, Yvonne C Wilkes, Yvonne E Lozano, Zerita White, Zoey A Trombley

Jennifer C Johnson's Documents

Publish Date Document Type Title
July, 2016 FDA 483 Response Richard K. Burt - Form 483R, 2016-07-22
March, 2013 EIR Balin, Martin S., MD, PhD - EIR, 2013-03-13
November, 2015 FDA 483 Azazuddin A. Ahmed, MD - Form 483, 2015-11-30
January, 2014 FDA 483 Response Danny H. Sugimoto, M.D. - Form 483R, 2014-01-14
March, 2013 FDA 483 Fresh Express - Form 483, 2013-03-21
July, 2016 FDA 483 Richard K. Burt - Form 483, 2016-07-11
June, 2014 FDA 483 Response Hodgson, Kim J., M.D. - Form 483R, 2014-06-25
June, 2014 FDA 483 Hodgson, Kim J., M.D. - Form 483, 2014-06-12
March, 2012 FDA 483 Response AlloSource - Form 483R, 2012-03-19
January, 2014 EIR Danny H. Sugimoto, M.D. - EIR, 2014-01-02
December, 2013 FDA 483 Response Alexian Brothers Hospital Network IRB - Form 483R, 2014-01-30
July, 2016 EIR Richard K. Burt - EIR, 2016-07-11
August, 2014 EIR Paul W. Crawford, MD - EIR, 2014-08-18
August, 2014 FDA 483 Paul W. Crawford, MD - Form 483, 2014-08-18
November, 2014 FDA 483 Dr. Luis Demetrio Gonzalez Patzan - Form 483, 2014-11-14
February, 2014 EIR Dr. Narendra Khippal - EIR, 2014-02-07
January, 2011 FDA 483 Tiny Greens - Form 483, 2011-01-28
March, 2013 FDA 483 Balin, Martin S., MD, PhD - Form 483, 2013-03-13
May, 2015 FDA 483 Response Danny H. Sugimoto, M.D. - Form 483R, 2015-06-09
May, 2015 FDA 483 Danny H. Sugimoto, M.D. - Form 483, 2015-05-20
January, 2014 EIR Azazuddin A. Ahmed, MD - EIR, 2014-01-23
September, 2016 FDA 483 Joseph R. Lentino, M.D. - Form 483, 2016-09-20
August, 2014 FDA 483 Response Paul W. Crawford, MD - Form 483R, 2014-09-08
June, 2012 EIR Vitalant - EIR, 2012-06-13
November, 2015 EIR Azazuddin A. Ahmed, MD - EIR, 2015-11-30
January, 2014 FDA 483 Danny H. Sugimoto, M.D. - Form 483, 2014-01-02
August, 2014 FDA 483 Satya P. Ahuja - Form 483, 2014-08-18
May, 2015 EIR Danny H. Sugimoto, M.D. - EIR, 2015-05-20
April, 2015 EIR Hospira, Inc. - EIR, 2015-04-13
December, 2012 EIR Sneeze Wheeze Itch Assoc - EIR, 2012-12-10
August, 2016 EIR Experimur, A Frontage Company - EIR, 2016-08-26
December, 2013 EIR Alexian Brothers Hospital Network IRB - EIR, 2013-12-12
August, 2012 FDA 483 Balin, Martin S., MD, PhD - Form 483, 2012-08-17
April, 2015 FDA 483 Response Hospira, Inc. - Form 483R, 2015-05-01
September, 2014 FDA 483 Larson, Richard A., M.D. - Form 483, 2014-09-05
September, 2016 EIR Joseph R. Lentino, M.D. - EIR, 2016-09-20
March, 2012 EIR AlloSource - EIR, 2012-03-12
June, 2016 FDA 483 Stephen C. Jensik - Form 483, 2016-06-09
November, 2015 FDA 483 Response Azazuddin A. Ahmed, MD - Form 483R, 2015-12-14
August, 2012 EIR Balin, Martin S., MD, PhD - EIR, 2012-08-17
September, 2014 EIR Larson, Richard A., M.D. - EIR, 2014-09-05
September, 2014 FDA 483 Response Larson, Richard A., M.D. - Form 483R, 2014-10-02
September, 2016 FDA 483 Response Joseph R. Lentino, M.D. - Form 483R, 2016-10-10
December, 2013 FDA 483 Alexian Brothers Hospital Network IRB - Form 483, 2013-12-12
April, 2015 FDA 483 Hospira, Inc. - Form 483, 2015-04-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more